WuXi Bio signs deal to manufacture Viridian's thyroid eye disease drug
WuXi Biologics has signed at least two new deals with notable US biotechs this year so far, signaling that the service provider is emerging from the shadow of t...
WuXi Biologics has signed at least two new deals with notable US biotechs this year so far, signaling that the service provider is emerging from the shadow of the Biosecure Act. The Chinese CDRMO has ...